AlphAIAlphAI — Financial news for AI agents
SEC EDGAR 8-KAUG 132 min read$NXXT

NextNRG Reports Second Quarter 2026 Financial Results

NEXTNRG, INC. (NXXT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 NextNRG Reports Second Quarter 2026 Financial Results Revenue Increased 41% Year-Over-Year to $27.7 Million as Net Loss is Down 82% and Adjusted EBITDA Loss Narrows 62% MIAMI, August 13, 2026 (GLOBE NEWSWIRE) — NextNRG, Inc. (NASDAQ: NXXT) (“NextNRG” or the “Company”

Original reporting
SEC EDGAR 8-K
Published Aug 13, 2026, 8:36 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 13, 2026, 8:40 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$NXXT
Neutral
low confidence
Mentioned
$NXXT
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$NXXTNeutralLow
01

Why it matters

The excerpt confirms the company released quarterly results for the quarter ended June 30, 2026, but provides no figures or guidance, limiting immediate trading inference.

02

Market read

Traders should treat this as an earnings-results disclosure event, but the excerpt lacks the specific financial datapoints needed to judge impact.

03

What to watch

Check Exhibit 99.1 for revenue, margins, cash burn, liquidity, and any forward-looking statements, which are typically what drive trading after an 8-K results release.

Relevance 7/10Novelty 3/10Timing: Filed Aug 13, 2026, after-hours/late session with Exhibit 99.1 results for quarter ended June 30, 2026.

Background

The filing is an SEC Form 8-K, Item 2.02, used to report quarterly financial results via a furnished press release (Exhibit 99.1).

Company-level read

Ticker impact

$NXXTNeutralLow confidence
Context

NextNRG filed an 8-K stating it issued a press release with financial results for the quarter ended June 30, 2026.

Expected impact

Near-term volatility possible on the actual results, but direction cannot be inferred from the provided excerpt.

Evidence & confidence

The 8-K confirms results were released and attached as Exhibit 99.1, yet the excerpt contains no numbers, outlook, or qualitative drivers.

Market effects

Sector

No sector read-through is provided in the excerpt beyond a routine quarterly results filing.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Because the excerpt omits the actual results, traders may overreact to the filing itself; the real catalyst is the content of Exhibit 99.1.

Key entities

  • company
    NEXTNRG, Inc.

    Subject of the 8-K filing, reporting quarterly results for the quarter ended June 30, 2026 via Exhibit 99.1.

  • executive
    Michael Farkas

    CEO signing the 8-K.

Read at source← All news

Related articles

AUG 20
$NXXTHigh

NextNRG (NXXT) Q2 2026 Earnings Call Transcript

NextNRG (NXXT) reported Q2 2026 revenue of $27.7M, up 40.9%, and reduced net loss by 81.7% YoY to $6.6M. The company cited growth in mobile fueling and lower operating expenses. Management highlighted strategic priorities: expanding mobile fueling, commercializing AI-driven smart microgrid tech, and growing EV charging infrastructure. NextNRG completed a $6.4M private placement to strengthen its balance sheet.

fool.com2 min
OCT 28
$FLEXHighAI 9/10

FLEX REPORTS SECOND QUARTER FISCAL 2027 RESULTS

FLEX LTD. (FLEX) filed an SEC Form 8-K — Results of Operations and Financial Condition. P R E S S R E L E A S E EXHIBIT 99.1 FLEX REPORTS SECOND QUARTER FISCAL 2027 RESULTS • Reported Q2 net sales of $8.5 billion, up 25% versus the prior year. • Delivered Q2 GAAP operating margin of 4.9%, and adjusted operating margin of 7.1%. • Reported Q2 GAAP EPS of $0.70, and re

SEC EDGAR 8-K2 min
OCT 28
$BIIBHighAI 8/10

Biogen Slips To Loss In Q3; Raises Low-end Of FY26 Earnings View

Biogen (BIIB) reported a Q3 loss of $20.6M, down from a $466.5M profit last year, despite an 11% revenue increase to $2.8B. Adjusted EPS was $2.62, down from $4.81. The loss was driven by transaction-related charges. Biogen raised its low-end FY26 EPS outlook to $12.20-$13.00, up from $12.00-$13.00. Shares were down 0.29% in premarket trading.

rttnews.com2 min
OCT 28
$NIHighAI 8/10

NiSource Q3 Net Income Rises

NiSource (NI) reported Q3 net income of $129.5M, or $0.27 per share, up from $94.7M, or $0.20 per share, in 2025. Revenues rose to $1.35B. The company narrowed 2026 EPS guidance to the upper half of $2.02-$2.07 and expects 2027 EPS of $2.22-$2.30. It extended its capital plan through 2033, with $40B in expenditures expected to drive 9-10% investment base growth and 10-11% EPS growth annually from 2027-2033.

rttnews.com2 min
OCT 28
$BLKBMed

Blackbaud Announces 2026 Third Quarter Financial Results

BLACKBAUD INC (BLKB) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 PRESS RELEASE Blackbaud Announces 2026 Third Quarter Financial Results Blackbaud Expands AI Leadership Through Numerous Innovation Announcements at bbcon User Conference Charleston, S.C. (October 28, 2026) — Blackbaud (NASDAQ: BLKB), the world's leading provider of A

SEC EDGAR 8-K3 min